Suppr超能文献

Cas9-crRNA 核糖核蛋白复合物介导细菌适应性免疫中的特异性 DNA 切割。

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

机构信息

Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.

出版信息

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86. doi: 10.1073/pnas.1208507109. Epub 2012 Sep 4.

Abstract

Clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide adaptive immunity against viruses and plasmids in bacteria and archaea. The silencing of invading nucleic acids is executed by ribonucleoprotein complexes preloaded with small, interfering CRISPR RNAs (crRNAs) that act as guides for targeting and degradation of foreign nucleic acid. Here, we demonstrate that the Cas9-crRNA complex of the Streptococcus thermophilus CRISPR3/Cas system introduces in vitro a double-strand break at a specific site in DNA containing a sequence complementary to crRNA. DNA cleavage is executed by Cas9, which uses two distinct active sites, RuvC and HNH, to generate site-specific nicks on opposite DNA strands. Results demonstrate that the Cas9-crRNA complex functions as an RNA-guided endonuclease with RNA-directed target sequence recognition and protein-mediated DNA cleavage. These findings pave the way for engineering of universal programmable RNA-guided DNA endonucleases.

摘要

成簇规律间隔短回文重复(CRISPR)/CRISPR 相关(Cas)系统为细菌和古菌提供了针对病毒和质粒的适应性免疫。通过预先加载有小的、干扰性 CRISPR RNA(crRNA)的核糖核蛋白复合物来执行对入侵核酸的沉默,这些 crRNA 充当靶向和降解外源核酸的向导。在这里,我们证明了嗜热链球菌 CRISPR3/Cas 系统的 Cas9-crRNA 复合物在含有与 crRNA 互补序列的 DNA 特定位点引入双链断裂。DNA 切割由 Cas9 执行,Cas9 使用两个不同的活性位点 RuvC 和 HNH,在相反的 DNA 链上产生特异性的切口。结果表明,Cas9-crRNA 复合物作为一种 RNA 指导的内切酶,具有 RNA 指导的靶序列识别和蛋白介导的 DNA 切割功能。这些发现为工程化通用可编程 RNA 引导的 DNA 内切酶铺平了道路。

相似文献

1
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86. doi: 10.1073/pnas.1208507109. Epub 2012 Sep 4.
2
crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
RNA Biol. 2013 May;10(5):841-51. doi: 10.4161/rna.24203. Epub 2013 Mar 27.
3
Programmable DNA cleavage in vitro by Cas9.
Biochem Soc Trans. 2013 Dec;41(6):1401-6. doi: 10.1042/BST20130164.
4
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Nature. 2016 Apr 28;532(7600):517-21. doi: 10.1038/nature17945. Epub 2016 Apr 20.
5
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012 Jun 28.
6
Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease.
J Biol Chem. 2014 May 9;289(19):13284-94. doi: 10.1074/jbc.M113.539726. Epub 2014 Mar 14.
7
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
RNA Biol. 2013 May;10(5):726-37. doi: 10.4161/rna.24321. Epub 2013 Apr 5.
8
In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus.
EMBO J. 2013 Feb 6;32(3):385-94. doi: 10.1038/emboj.2012.352. Epub 2013 Jan 18.
9
Substrate generation for endonucleases of CRISPR/cas systems.
J Vis Exp. 2012 Sep 8(67):4277. doi: 10.3791/4277.
10
Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.
Mol Cell. 2014 Nov 20;56(4):506-17. doi: 10.1016/j.molcel.2014.09.027. Epub 2014 Nov 6.

引用本文的文献

1
Conformational changes induced by K949A mutation in the CRISPR-Cas12a complex drives an effective target-binding mechanism.
Curr Res Struct Biol. 2025 Aug 8;10:100173. doi: 10.1016/j.crstbi.2025.100173. eCollection 2025 Dec.
2
CRISPR/Cas13-Based Anti-RNA Viral Approaches.
Genes (Basel). 2025 Jul 25;16(8):875. doi: 10.3390/genes16080875.
5
Structural insights into Type II-D Cas9 and its robust cleavage activity.
Nat Commun. 2025 Aug 11;16(1):7396. doi: 10.1038/s41467-025-62128-8.
6
The hidden risks of CRISPR/Cas: structural variations and genome integrity.
Nat Commun. 2025 Aug 5;16(1):7208. doi: 10.1038/s41467-025-62606-z.
7
Unveiling the invisible genomic dynamics.
Exp Mol Med. 2025 Jul;57(7):1400-1408. doi: 10.1038/s12276-025-01434-z. Epub 2025 Jul 31.
8
Cas9-independent tracrRNA cytotoxicity in .
Microlife. 2025 Jul 3;6:uqaf013. doi: 10.1093/femsml/uqaf013. eCollection 2025.
10
Customised virus-like particles: Opening a new chapter for clinical precision gene therapy.
Clin Transl Med. 2025 Jul;15(7):e70395. doi: 10.1002/ctm2.70395.

本文引用的文献

1
CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3.
Mol Cell. 2012 Jun 8;46(5):595-605. doi: 10.1016/j.molcel.2012.03.018. Epub 2012 Apr 19.
2
RNA-guided genetic silencing systems in bacteria and archaea.
Nature. 2012 Feb 15;482(7385):331-8. doi: 10.1038/nature10886.
3
Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.
Mol Cell. 2012 Feb 10;45(3):292-302. doi: 10.1016/j.molcel.2011.10.023. Epub 2012 Jan 5.
4
Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.
Mol Cell. 2012 Feb 10;45(3):303-13. doi: 10.1016/j.molcel.2011.12.013. Epub 2012 Jan 5.
6
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
Nucleic Acids Res. 2011 Nov;39(21):9275-82. doi: 10.1093/nar/gkr606. Epub 2011 Aug 3.
7
Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence.
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10098-103. doi: 10.1073/pnas.1104144108. Epub 2011 Jun 6.
8
Evolution and classification of the CRISPR-Cas systems.
Nat Rev Microbiol. 2011 Jun;9(6):467-77. doi: 10.1038/nrmicro2577. Epub 2011 May 9.
9
Structural basis for CRISPR RNA-guided DNA recognition by Cascade.
Nat Struct Mol Biol. 2011 May;18(5):529-36. doi: 10.1038/nsmb.2019. Epub 2011 Apr 3.
10
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.
Nature. 2011 Mar 31;471(7340):602-7. doi: 10.1038/nature09886.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验